Skip to main content
Log in

The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia

Die Wirksamkeit von strikter reverser Isolation und antimikrobieller Dekontamination bei der Induktionstherapie der akuten LeukÄmie

  • Original Works
  • Published:
Blut Aims and scope Submit manuscript

Zusammenfassung

Die Wirksamkeit von strikter reverser Isolation und antimikrobieller Dekontamination bei der Induktionstherapie der akuten LeukÄmie wurde retrospektiv bei 47 Patienten untersucht. Alle Patienten erhielten eine standardisierte aggressive Chemotherapie mit Daunorubicin und Cytosin-Arabinosid. Zweiundzwanzig Patienten wurden in strikter reverser Isolation mit antimikrobieller Dekontamination behandelt, 25 Patienten auf normalen Krankenstationen ohne Ma\nahmen zur Infektionsprophylaxe. Die HÄufigkeit neuer Infektionen pro Patient war 0,77 bei den isolierten Patienten und 1,42 in der Kontrollgruppe. Die Rate kompletter Remissionen betrug bei den isolierten Patienten 77% im Vergleich zu 56% bei den Patienten auf den normalen Krankenstationen.

Summary

The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia was studied retrospectively in 47 patients who were treated with a standardized aggressive chemotherapy of daunorubicin and cytosine arabinoside. Twenty-two patients were treated in strict reverse isolation with antimicrobial decontamination and 25 patients in the open ward without any measures against infections. In the patients in isolation the incidence of new infections per patient was 0.77 compared to 1.42 in the control group. The rate of complete remissions was 77% in the patients in isolation vs. 56 % in the control patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bodey GP, Gehan EA, Freireich EJ, Frei E (1971) Protected environment-prophylactic antibiotic programm in the chemotherapy of acute leukemia. Am J Med Sci 262: 138–159

    Google Scholar 

  2. Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ (1976) Causes of death in adults with acute leukaemia. Medicine 55: 259–268

    Google Scholar 

  3. Dietrich M, Abt C, Pflieger H (1975) Experiences with a new isolated bed system in the treatment of acute leukaemia. Med Prog Technol 3: 85–89

    Google Scholar 

  4. Dietrich M, Abt C, Arnold R, Hoelzer D, Kurrle E, Rasche H, Kubanek B, Heimpel H, Fliedner TM (1979) Die Wirksamkeit gnotobiotischer Ma\nahmen bei der Behandlung der akuten LeukÄmie. Onkologie 2: 102–107

    Google Scholar 

  5. EORTC Gnotobiotic Project Group Writing Committee: Dietrich M, Gaus W, Vossen JM, van der Waaij D, Wendt F (1977) Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. I. Clinical results. Infection 5: 107–114

    Google Scholar 

  6. EORTC Gnotobiotic Project Group Writing Committee: Dankert J, Gaus W, Gaya H, Krieger D, Linzenmeier G, van der Waaij D (1978) Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. III. The quality of isolation and decontamination. Infection 6: 175–191

    Google Scholar 

  7. Gale RP, Cline MJ (1977) High remission induction rate in acute myeloid leukaemia. Lancet I: 497–499

    Google Scholar 

  8. Hersh EM, Bodey GP, Nies BA, Freireich EJ (1965) Causes of death in acute leukaemia. JAMA 193: 105–109

    Google Scholar 

  9. Kurrle E, Abt C, Bhaduri S, Heimpel H, Krieger D, Vanek E, Kubanek B (1979) Possibilities and problems of protective isolation and antimicrobial decontamination in man. Zentralbl Bakteriol [Suppl] 7: 63–66 (1979)

    Google Scholar 

  10. Levine AS, Siegel SE, Schreiber AD, Hauser J, Preisler H, Goldstein JM, Seidler F, Simon R, Perry S, Bennett J, Henderson ES (1973) Protected environments and prophylactic antibiotics. N Engl J Med 288: 477–483

    Google Scholar 

  11. Pizzo PA, Levine AS (1977) The utility of protected environment regimens for the compromised host: a critical assessment. Prog Hematol 10: 311–332 (1977)

    Google Scholar 

  12. Rodriguez V, Bodey GP, Freireich EJ, McCredie KB, Gutterman JV, Keating MJ, Smith TL, Gehan EA (1978) Randomized trial of protected environment-prophylactic antibiotics in 145 adults with acute leukemia. Medicine 57: 253–266

    Google Scholar 

  13. Schimpff SC, Greene WH, Young VM, Fortner CL, Jepsen L, Cusack H, Block JB, Wiernik PH (1975) Infection prevention in acute nonlymphocytic leukaemia. Ann Intern Med 82: 351–358

    Google Scholar 

  14. Valdivieso M (1976) Bacterial infection in haematological disease. Clin Haematol 5: 229–248

    Google Scholar 

  15. Yates JW, Holland JF (1973) A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer 32: 1490–1498

    Google Scholar 

  16. Yates JW, Wallace J, Ellison RR, Holland JF (1973) Cytosine arabinoside and daunorubicin therapy in acute nonlymphocytic leukaemia. Cancer Chemother Rep 57: 485–488

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the Deutsche Forschungsgemeinschaft, SFB 112, Projekt E 1

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurrle, E., Bhaduri, S., Heimpel, H. et al. The efficiency of strict reverse isolation and antimicrobial decontamination in remission induction therapy of acute leukemia. Blut 40, 187–195 (1980). https://doi.org/10.1007/BF01008576

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01008576

Schlüsselwörter

Key words

Navigation